[Results of a multidisciplinary program to quit smoking]
Pedro Peña1, Mónica Zagolin, Mónica Acuña
1Departamento de Enfermedades Respiratorias, Clínica Santa María, Santiago, Chile. ppena@csm.cl
Revista Medica De Chile
|August 1, 2013
Summary
A multidisciplinary smoking cessation program achieved a 49% success rate over one year. This program combined counseling, psychological therapy (PT), and pharmacotherapy, with varenicline being the most common medication. A history of depression was associated with lower success rates.
Area of Science:
- Addiction Medicine
- Behavioral Science
- Pharmacotherapy
Background:
- Standard smoking cessation therapies include counseling, psychological therapy (PT), nicotine replacement therapy, bupropion, and varenicline.
- Multidisciplinary approaches integrate various strategies to enhance smoking cessation outcomes.
Purpose of the Study:
- To evaluate the effectiveness of a multidisciplinary smoking cessation program.
- To identify factors associated with successful smoking abstinence.
Main Methods:
- Adult patients motivated to quit smoking participated in a program combining counseling and PT, with optional pharmacotherapy.
- Follow-up assessments were conducted via telephone for one year.
- Patients with unstable psychiatric conditions were excluded, and logistic regression analysis was used to determine predictors of success.
Main Results:
- The study included 198 patients (45 ± 11 years, 56% males) who smoked 31.5 ± 20.6 packages/year.
- Varenicline was used by 78% of patients, bupropion by 13%, and 17% received no pharmacotherapy.
- A 49% abstinence rate was achieved after one year, with a history of depression negatively associated with success (OR=4).
- Common side effects included nausea (37% for varenicline, 23% for bupropion) and sleep disturbances (20% for varenicline, 19% for bupropion).
Conclusions:
- A multidisciplinary smoking cessation program demonstrated a 49% success rate in maintaining abstinence for one year.
- The findings highlight the efficacy of integrated smoking cessation strategies.
- History of depression may be a factor to consider in smoking cessation treatment planning.
Related Concept Videos
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.